David J McCormack MFSTEd FRCSEd (CTh) Advanced Clinical Fellow

Slides:



Advertisements
Similar presentations
Off pump CABG has been performed for the first time 40 years ago. Although conventional CABG is considered both safe and effective, the use of CBP.
Advertisements

Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
MAIN-COMPARE Study Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease.
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
Introduction Recent guidelines considered PCI to be a potential alternative to CABG for ULMCA stenosis, based on several large registries and randomized.
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
The INSIGHT study - Reliable blood pressure control and additional benefits for hypertensive patients Anthony M Heagerty Department of Medicine Manchester.
FFR vs Angiography for Multivessel Evaluation
ARTS I & II Keith D Dawkins Southampton University Hospital.
5 Years Results of Off-Pump VS On-Pump CABG 5 Years Results of Off-Pump VS On-Pump CABG Prospective Non-randomized Comparative Study Piya Cherntanomwong*,
PCI VS CABG JOURNAL REVIEW
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
Preservation Solutions, Vein Graft Patency, and Outcomes after Coronary Bypass Surgery RE Harskamp, JH Alexander, PJ Schulte, CM Brophy, MJ Mack, ED Peterson,
Blood Pressure Lability During Cardiac Surgery Is Associated With Adverse Outcomes Solomon Aronson, Edwin G. Avery, Cornelius Dyke, Joseph Varon, Jerrold.
Coronary Artery Disease in Diabetic Patients, Different from Non-diabetics?
Secondary Prevention Following Coronary Artery Bypass Grafting: are we Compliant with the Guidelines? V. Joshi, B. Bridgewater University Hospital of South.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures.
André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures.
Randomized Trial of Ea rly S urgery Versus Conventional Treatment for Infective E ndocarditis (EASE) Duk-Hyun Kang, MD, PhD on behalf of The EASE Trial.
Impact of early surgery vs conventional treatment for infective endocarditis on mortality and embolic events: data from EASE trial Prospective RCT ( );
Swain 23 Oct Embol-X Clinical Reviewers Wolf Sapirstein M.D. Julie Swain M.D. (Cardiothoracic Surgery)
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
Trial Design Issues Associated with Evaluation of Distal Protection Devices in Diseased Saphenous Vein Grafts Bram D. Zuckerman, MD, FACC Medical Officer,
Effect Of European Working Time Directive On Training And Outcome Following Coronary Artery Bypass Grafting Mohamad Bashir, Mark Field, Abbas Rashid, Matthew.
4S: Scandinavian Simvastatin Survival Study
Baseline Characteristics of the Patients* - Part I The ONTARGET Investigators. N Engl J Med 2008 [Epub on Mar 31]
Circulatory System Devices Panel Questions for Discussion EMBOL·X Aortic Filter October 23, 2002.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
On and Off Pump Coronary Artery Bypass Grafting (CABG) David Kim Independent Research GT.
Angela Aziz Donnelly April 5, 2016
CABG IN DIABETICS DR. SEYED SAEED FARZAM. Introduction Patients with diabetes mellitus Increased incidence of CAD More extensive disease at angiography.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
The Impact of Preoperative Renal Dysfunction on the Outcomes of Patients Undergoing Transcatheter Aortic Valve Replacement Andres M. Pineda MD, J. Kevin.
Total Occlusion Study of Canada (TOSCA-2) Trial
The German Off-Pump Coronary Artery Bypass Grafting in
The SPRINT Research Group
Early Surgery versus Conventional Treatment for Infective Endocarditis
Jeff Macemon MBChB, PDMSM Advanced Trainee, CTS
Updates From NOTION: The First All-Comer TAVR Trial
Joseph Zacharias & Bilal Kirmani Lancashire Cardiac Centre Blackpool
Damian Gimpel Waikato Cardiothoracic Unit Journal Club
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With Three-Vessel Disease and/or Left Main Disease Patrick.
PRESENTER NAME Waikato Cardiothoracic Unit Journal Club
Damian Gimpel Waikato Cardiothoracic Unit Journal Club
CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump
Balloon-pump assisted Coronary Intervention Study (BCIS-1):
AIM HIGH Niacin plus Statin to prevent vascular events
RAAS Blockade: Focus on ACEI
Jeff Macemon Waikato Cardiothoracic Unit
Nishith Patel Waikato Cardiothoracic Unit
Systolic Blood Pressure Intervention Trial (SPRINT)
The following slides highlight a presentation at the Late-Breaking Clinical Trials session of the American Heart Association Scientific Sessions, November.
CRASH 2 Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2):
Section 7: Aggressive vs moderate approach to lipid lowering
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
American Heart Association Presented by Dr. Julinda Mehilli
Sildenafil for Improving Outcomes in Patients With Corrected Valvular Heart Disease and Persistent Pulmonary Hypertension: A Multicenter, Double-Blind,
The following slides highlight a report on a presentation at a Late-Breaking Trial Session of the European Society of Cardiology Congress 2004 held in.
for the REGROUP Trial Investigators
Satya Shanbhag Waikato Cardiothoracic Unit
LRC-CPPT and MRFIT Content Points:
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Atlantic Cardiovascular Patient Outcomes Research Team
Presentation transcript:

David J McCormack MFSTEd FRCSEd (CTh) Advanced Clinical Fellow Cardiothoracic Journal Club ROOBY Trial (Veterans Affairs Randomised On/Off Bypass) David J McCormack MFSTEd FRCSEd (CTh) Advanced Clinical Fellow

What proportion of Waikato patients is ROOBY applicable to? 5% 20% 50% 90%

Off-Pump Proposed Advantages Off-Pump Proposed Challenges No aortic cannulation No atrial cannulation No cross-clamping No blood-plastic interface No cardioplegia K+ load fluid load coronary air embolism No risk of bypass machine failure -> air embolism Less cost Less equipment Less staff Needs skilled staff Technically more difficult Not all coronary arteries easily reached by technique Potential for MI without cardioplegia Incomplete revascularisation more frequent. Worse long-term graft patency Proposed neuropsychological benefit not shown in trial Difficult in diffuse disease or small artery disease

Hypothesis or objective ‘We hypothesised there would be no difference between the on-pump and off-pump procedures for the two primary outcomes’ Primary Outcomes Major morbidity and mortality at 1 month Major morbidity and mortality at 1 year Secondary Outcomes Completeness of revascularisation 1-year graft patency Neuropsychological test scores

Methods – Study Design The ROOBY trial was a controlled, single-blind, randomized trial conducted from February 2002 through May 2008 at 18 VA medical centres. Participating surgeons were required to document that they had performed at least 20 off-pump CABG surgeries, including some in which complete revascularization was performed for all vascular territories of the heart. The pre-study off-pump experience of the surgeons averaged 120 cases (median, 50). Sixteen sites had training programs in which cardiothoracic trainees (postgraduate year 6 to 10) were designated before randomization as the primary surgeon or first assistant surgeon. Postoperatively, enrolled patients were followed every 2 months for up to 1 year.

Methods – Inclusion Criteria Patients undergoing isolated CABG surgery Scheduled or elective procedures

Methods – Exclusion Criteria Any clinically significant valve disease (i.e., moderate, moderate-to-severe, or severe valve disease). Requiring immediate surgery. Small target vessels (<1.1 mm in internal diameter) or diffuse coronary disease. Clinical reservations of the surgical team regarding patients with risk-factor profiles that predisposed them to an extremely high risk of an adverse event. The inability or unwillingness of the patient to provide consent.

Methods – Randomisation While in the preoperative holding area, patients underwent randomization. Automated central telephone system in a blocked randomization scheme. Assignments of the patients were balanced for each attending surgeon.

Methods – Surgical Details A standard median sternotomy was performed in all patients. Mandatory use of stabilisation device for off-pump surgery. Conversion from the assigned procedure to the other procedure was performed when clinically necessary

Methods – Primary Endpoints Short-term composite end point (<30d / discharge) death reoperation new mechanical support cardiac arrest, coma, Stroke renal failure requiring dialysis Long-term composite end point (30d – 1y) death from any cause nonfatal myocardial infarction repeat revascularization “Composite end points were selected for feasibility and fiscal reasons”

Methods – Secondary Endpoints Completeness of revascularization (determined by the number of graft s performed as compared with the number planned) Graft patency at 1 year Scores on a battery of neuropsychological tests which were performed preoperatively and 1 year post- operatively.

Methods – Statistical Analysis Power calculation indicated a sample size of 2200 patients Two-tailed continuity-corrected chi-square test. P value of 0.05 to indicate statistical significance for primary end points, Power of 0.80, a 10% rate of loss to follow-up, and the ability to detect a reduction of 40% in the rate of the primary 1-year composite end point in the off-pump group as compared with the expected 8% rate in the on-pump group. This sample size also allowed the detection of a 30% reduction in the primary short-term composite endpoint from the expected 14% rate in the on-pump group.

Methods – Statistical Analysis The two primary end points – continuity corrected chi square tests. Study-centre effects – Mantel–Haenszel chi-square tests. Baseline characteristic and secondary outcomes were compared with the use of chi-square techniques and t-tests as appropriate. Log-rank tests with On-Pump versus Off-Pump Coronary-Artery Bypass Surgery Kaplan–Meier curves were used to report time to death.

Results Consort Diagram

Results – Baseline Characteristics

Results – Baseline Characteristics

Results – Baseline Characteristics

Results – Primary Endpoints

Results – Primary Endpoints

Results – Primary Endpoints

Results – Secondary Enpoints

Results – Secondary Endpoints

Results – Secondary Endpoints Less grafts performed in off-pump group. More patients ‘undergrafted’ in off-pump group.

Conclusion Our trial did not show any overall advantage to the use of the off-pump as compared with the on-pump cardiac surgical approach for coronary bypass. Instead, there was a consistent trend toward better outcomes in patients undergoing the conventional on- pump CABG technique. This including better 1-year composite outcomes and 1-year patency rates. No significant differences between the off-pump and the on-pump techniques were identified in neuropsychological outcomes or the use of major resources.

Strengths of the study Prospective, controlled, randomised and blinded trial. Large multicentre trial. Achieved sufficient patients to power study. Impressive angiographic follow up Good clinical follow up rate (XX %)

Limitations of the study Surgical intervention not performed by experts. Minimum of 20 cases with some cases grafting all coronary territories. Self documentation of experience (expertise). Residents cases included. Large cohort of patients excluded Limited description of 3282 excluded patients (44% of eligible patients) Limited applicability to our local cohort. No standard operation in either limb.

Limitations of the study No description of reason for cross over Off-pump -> on-pump (12.4%) On-pump -> off-pump (3.6%) Historic study CORONARY Trial On/Off Trial Cologne Metanlysis GOPCABE

General Discussion Points Landmark paper – largely negative for off-pump. Less grafts per patient in off-pump surgery (2.9 vs 3.0). What level of experience should be required? Should resident cases be performed? Intention to treat analysis not used.

What proportion of Waikato Patients is ROOBY applicable to? 5% 20% 50% 90%